Fundrise Innovation Is Not Worth Getting Up For

Fundrise Innovation provides investors access to top private companies like SpaceX, Anthropic, and Anduril, but there is a catch. It is a listed closed-end fund, and like Destiny Tech100 did in April 2024, it trades at a massive premium to the fund’s net asset value.

As of market close on March 24, 2026, Fundrise Innovation’s premium reached more than 1,500%. That implies a roughly $27 trillion market value for SpaceX, or roughly half the value of the entire S&P 500, based on its reported $1.75 trillion targeted IPO valuation. For those buying shares of Fundrise Innovation now, this means much, if not all, of their upside is already gone, whether they know it or not. Additionally, at least 42% of the fund’s holdings are accessed via special-purpose vehicles and do not represent direct ownership of the companies themselves. As seen in the ERShares Private-Public Crossover ETF, such SPV structures can eat meaningfully into returns.

Refresher on CEFs

Fundrise Innovation is a former semiliquid tender-offer fund that recently converted to a listed closed-end fund. In its old structure, investors could redeem shares quarterly at the fund’s net asset value, but only 5% of the fund was eligible for repurchase each quarter. In its current form, investors can buy or sell at will, but on an exchange at market prices. The market price of CEFs can diverge meaningfully from the funds’ net asset values, which is the fair value per share of a fund based on the value of the underlying portfolio holdings, less some accrued costs and any liabilities. This differs from mutual funds, in which investors buy and sell once per day at the fund’s ending NAV, which means mutual fund investors always get fair value for their shares.

Listed closed-end funds also differ from exchange-traded funds. While they both trade on exchanges, ETFs have creation and redemption mechanisms that allow market makers to arbitrage away any premiums or discounts. Since CEFs invest static pools of capital and do not create or redeem shares as part of their daily operations, there is no arbitrage mechanism to keep the price anchored to the NAV.

A portfolio of private companies complicates this picture. Fund NAVs are based on the fair values of the underlying holdings, which for public equities or debt is simply the securities’ market prices. Determining the fair values of private companies is trickier. Since they don’t actively trade, it can be anyone’s guess, though funds that own privates typically value them as of their last known financing round or secondary trade. Proponents of CEFs like Fundrise Innovation and DestinyTech 100 DXYZ argue that these vehicles aid in price discovery, that is, they help uncover the true value of the underlying private companies. While there is merit to that argument, it’s hard to believe the private markets mispriced Fundrise Innovations’ holdings by a factor of 15.

Current Fundrise Innovation buyers are essentially betting that the fund’s share price will become even more estranged from its NAV. That may work out in the short run if market exuberance continues, but in the long run, cooler heads will prevail, and the premium is almost sure to collapse, especially when a six-month lockup period prevents shareholders who owned the fund before it became a CEF from selling expires.

The Destiny Tech100 Lesson

Fundrise is not the first CEF to trade at such a massive premium. Destiny Tech100 at one point in early 2024 traded at a 2,000% premium to its NAV. That fund was popular for many of the same reasons as Fundrise Innovation: It gave investors access to private companies like SpaceX that were otherwise hard to buy for everyday investors. In the rush to get exposure to such holdings, clearly some investors were either willing to ignore valuations, bake the upfront premium into their expected return, or, most worryingly, simply unaware that, unlike mutual funds and ETFs, CEFs can trade at huge premiums.

For example, if you bought Destiny Tech100 when it first traded at a 1,000% premium on April 5, 2024, your opportunity for profits was exceedingly slim. You could’ve made money if you were a sage short-term trader and sold within a day or two when the premium continued to rise, but such prescience is so rare as to be almost nonexistent. Otherwise, the massive upfront premium virtually guaranteed a steep loss because maintaining such premiums requires a never-ending game of hot potato.

The 2024 election breathed new life into Destiny Tech100 and presented an opportunity for profit, as the portfolio’s holdings were seen as beneficiaries of a Trump win. On the eve of the Nov. 5 election, the position would have been down 80%. However, the postelection risk rally through December could have allowed an investor to exit at around a 23% gain if timed perfectly. Yet, that was only slightly better than the S&P 500’s 19% rise in that same period, and even that rally was short-lived. And let’s be honest, if you held through that much pain, would you really sell for a measly 23% profit?

Still, the aforementioned price discovery argument has some merit. Destiny Tech100’s NAV, after all, increased nearly 300% in that same period, much more than the S&P 500’s 31% return. So, in a sense, the market was right to trade the portfolio at a premium. If your goal was to get market-beating returns, in theory and with perfect foresight, you would have been willing to pay up to a 200% premium in April 2024 ($15.24 per share) for the fund based on its latest $19.97 NAV (Destiny Tech100’s massive premium has almost entirely collapsed, and it traded at 21% premium as of March 23). Of course, that assumes an omniscience none of us have, and a 200% premium is a fraction of the 2,000% premium that the fund actually once traded at. So, it’s not inconceivable that a portfolio of hard-to-price private companies would trade at a premium, but it is hard to argue that a 1,000% or more premium could ever make sense.

Beware of the Lockup Cliff

Things seemed to be going relatively well for Fundrise Innovation when it operated in a semiliquid tender-offer structure. So why list as a closed-end fund? The fund company explicitly argued in its proxy statement that it thought the fund would trade at a premium, which would benefit exiting investors. So far, it has been right. The company also outlined daily liquidity as a benefit, though, unlike another semiliquid fund that converted to a CEF, this fund did not have any obvious liquidity issues before the listing.

The immediate liquidity and premium benefits are not accruing to longtime shareholders, though. Longtime owners of the tender-offer fund are unable to sell their shares right now, as they are subject to a six-month lockup period. The shares trading right now are only those shares purchased after Feb. 20, 2026. This odd setup rewards newcomers potentially at the expense of the more loyal investors. Who are the new shareholders? It is hard to tell, but according to Bloomberg, only about 10% of the fund’s shares are trading right now.

The fund company benefited from the conversion, as the listing created a permanent fee-paying asset base, and the listing came complete with a fee hike. The management fee was pushed up to 2.50% from 1.85%, leaving it tied with Destiny Tech100 as the two most expensively priced CEFs in the market.

It is highly unlikely that Fundrise Innovation’s massive premium will persist for six months. But even if it does, once the lockup expires, there will likely be significant selling pressure, forcing the price down. So, if anyone is thinking about owning this fund for the long run, consider waiting until September.